+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biperiden Market - Global Forecast 2026-2032- Product Image
Biperiden Market - Global Forecast 2026-2032- Product Image
New

Biperiden Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 193 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082731
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Biperiden remains a cornerstone medication in managing movement disorders, offering consistent therapeutic value while adapting to shifting operational, clinical, and procurement strategies. Senior decision-makers must stay attentive to the evolving dynamics of the biperiden market to maintain both care continuity and organizational efficiency in a complex pharmaceutical environment.

Market Snapshot: Biperiden Market Trends

The biperiden market advanced from USD 407.10 million in 2025 to USD 433.97 million in 2026, with projections indicating further expansion at a CAGR of 6.60% and an anticipated total of USD 636.93 million by 2032. This continued growth is supported by a blend of generic availability, enduring clinical requirement, and resilient supply frameworks. Biperiden’s diverse therapeutic applications and established range of administration routes contribute to its relevance across both institutional and at-home care settings.

Biperiden Market Scope & Segmentation

  • Formulations: Oral tablets offered in 2 mg and 4 mg strengths, as well as parenteral injectables, equip healthcare providers with flexible dosing tailored to both acute and long-term management.
  • Type: Availability of branded and generic products enables competitive procurement strategies, influencing price negotiations and supply consistency for buyers.
  • Indications: Utilized primarily in treating drug-induced extrapyramidal symptoms, and as adjunctive therapy for various movement disorders, supporting targeted therapeutic planning.
  • Administration Route: Oral options facilitate ease of use in outpatient and residential settings, while injectables remain essential for acute care and hospital use cases.
  • Age Groups: Tailored approaches for adult and geriatric populations address differing risk profiles and necessitate careful medication review, particularly in older cohorts.
  • End-Use Settings: Hospitals, clinics, and home-care agencies each prioritize unique distribution patterns, service levels, and provider support needs.
  • Regional Markets: The Americas, Europe/Middle East & Africa, and Asia-Pacific each present specific regulatory, operational, and logistical considerations that affect adoption rates and local partnerships.

Key Takeaways for Strategic Leaders

  • Biperiden’s anticholinergic mechanism underpins its recognized position in movement disorder care, requiring heightened individual risk management, especially in older adult patients.
  • Market success depends less on exclusivity and more on manufacturing reliability, agile supply chains, and differentiators such as advanced packaging and comprehensive customer support.
  • Recent tariff adjustments have heightened the importance of diversified sourcing, moving organizations toward more regional production footprints and strategic alliances to safeguard supply stability.
  • Sophisticated buyers, including institutional pharmacies, increasingly value transparent communication from suppliers and measurable quality assurance during a period of shifting trade and regulatory landscapes.
  • Collaborative partnerships between generic producers and local distributors are streamlining entry into new markets and addressing both infrastructure and policy complexities.
  • Enhanced packaging, improved caregiver and patient support services, and innovation in distribution logistics now play a vital role alongside price when procurement success is evaluated.

Tariff Impact on Sourcing and Distribution

Recent changes in tariff policy and trade measures up to 2025 have significantly influenced procurement strategies, drawing focus to comprehensive cost factors and the operational value of group purchasing organizations. Manufacturers are adapting by embedding tariff risk management into supply agreements and developing multi-source strategies to ensure product availability despite frequent regulatory shifts. Hospitals, in response, implement flexible sourcing protocols and strengthen relationships with suppliers to mitigate risks of therapy interruption.

Methodology & Data Sources

This analysis leverages peer-reviewed clinical studies, regulatory records, and pharmacovigilance data, complemented by insights from clinicians, procurement professionals, and supply chain experts. Cross-validation of findings ensures the report’s recommendations are grounded in practical, real-world procurement and care scenarios.

Why This Report Matters

  • Empowers pharmaceutical leaders to optimize product portfolios and adapt to regulatory and supply chain developments.
  • Enables healthcare institutions to select suppliers and solutions that balance medical outcomes, operational resilience, and risk mitigation.
  • Guides manufacturers and distribution partners in aligning investment and service innovation with evolving market and policymaker expectations.

Conclusion

Sustaining biperiden access and adoption will depend on adaptive operations and a commitment to transparent, patient-centered support. Strategic procurement and collaborative approaches remain central to shaping long-term biperiden market opportunities.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biperiden Market, by Formulation
8.1. Injectable
8.2. Oral
8.2.1. 2 mg
8.2.2. 4 mg
9. Biperiden Market, by Type
9.1. Branded
9.2. Generic
10. Biperiden Market, by Indication
10.1. Extrapyramidal Symptoms
10.2. Parkinson's Disease
11. Biperiden Market, by Route Of Administration
11.1. Oral
11.2. Parenteral
12. Biperiden Market, by Patient Age Group
12.1. Adults
12.2. Geriatric
13. Biperiden Market, by End-User
13.1. Clinics
13.2. Home Care
13.3. Hospitals
14. Biperiden Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Biperiden Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Biperiden Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Biperiden Market
18. China Biperiden Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Apotex Inc.
19.6. Aurobindo Pharma Limited
19.7. Dr. Reddy's Laboratories Ltd.
19.8. Glenmark Pharmaceuticals Limited
19.9. Janssen-Cilag International NV
19.10. Lupin Limited
19.11. Sandoz International GmbH
19.12. Sun Pharmaceutical Industries Ltd.
19.13. Teva Pharmaceutical Industries Ltd.
19.14. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL BIPERIDEN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIPERIDEN MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIPERIDEN MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIPERIDEN MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIPERIDEN MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIPERIDEN MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIPERIDEN MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIPERIDEN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIPERIDEN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES BIPERIDEN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA BIPERIDEN MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIPERIDEN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIPERIDEN MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIPERIDEN MARKET SIZE, BY 2 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIPERIDEN MARKET SIZE, BY 2 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIPERIDEN MARKET SIZE, BY 2 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIPERIDEN MARKET SIZE, BY 4 MG, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIPERIDEN MARKET SIZE, BY 4 MG, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIPERIDEN MARKET SIZE, BY 4 MG, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIPERIDEN MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIPERIDEN MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIPERIDEN MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIPERIDEN MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIPERIDEN MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIPERIDEN MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIPERIDEN MARKET SIZE, BY EXTRAPYRAMIDAL SYMPTOMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIPERIDEN MARKET SIZE, BY EXTRAPYRAMIDAL SYMPTOMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIPERIDEN MARKET SIZE, BY EXTRAPYRAMIDAL SYMPTOMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON'S DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIPERIDEN MARKET SIZE, BY PARKINSON'S DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIPERIDEN MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIPERIDEN MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIPERIDEN MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIPERIDEN MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIPERIDEN MARKET SIZE, BY ADULTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIPERIDEN MARKET SIZE, BY ADULTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIPERIDEN MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIPERIDEN MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIPERIDEN MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIPERIDEN MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIPERIDEN MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIPERIDEN MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIPERIDEN MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIPERIDEN MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIPERIDEN MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIPERIDEN MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIPERIDEN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIPERIDEN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIPERIDEN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIPERIDEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS BIPERIDEN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 65. NORTH AMERICA BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 71. LATIN AMERICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. LATIN AMERICA BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 73. LATIN AMERICA BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 87. EUROPE BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. EUROPE BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 89. EUROPE BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 90. EUROPE BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 91. EUROPE BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 92. EUROPE BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 93. EUROPE BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 94. EUROPE BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 95. MIDDLE EAST BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. MIDDLE EAST BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 97. MIDDLE EAST BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 103. AFRICA BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. AFRICA BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 105. AFRICA BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 106. AFRICA BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 107. AFRICA BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 108. AFRICA BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 109. AFRICA BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 110. AFRICA BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BIPERIDEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. ASEAN BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. ASEAN BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 122. ASEAN BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 123. ASEAN BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 124. ASEAN BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 125. ASEAN BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 126. ASEAN BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 127. ASEAN BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 128. GCC BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. GCC BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 130. GCC BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 131. GCC BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 132. GCC BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 133. GCC BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 134. GCC BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 135. GCC BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 136. EUROPEAN UNION BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. EUROPEAN UNION BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 138. EUROPEAN UNION BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 144. BRICS BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. BRICS BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 146. BRICS BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 147. BRICS BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 148. BRICS BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 149. BRICS BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. BRICS BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 151. BRICS BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 152. G7 BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. G7 BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 154. G7 BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 155. G7 BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 156. G7 BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 157. G7 BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. G7 BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 159. G7 BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 160. NATO BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. NATO BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 162. NATO BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 163. NATO BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 164. NATO BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 165. NATO BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. NATO BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 167. NATO BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL BIPERIDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES BIPERIDEN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 177. CHINA BIPERIDEN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 178. CHINA BIPERIDEN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 179. CHINA BIPERIDEN MARKET SIZE, BY ORAL, 2018-2032 (USD MILLION)
TABLE 180. CHINA BIPERIDEN MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
TABLE 181. CHINA BIPERIDEN MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 182. CHINA BIPERIDEN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. CHINA BIPERIDEN MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 184. CHINA BIPERIDEN MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Biperiden market report include:
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Limited
  • Janssen-Cilag International NV
  • Lupin Limited
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 433.97 Million
Forecasted Market Value ( USD ) by 2032 $ 636.93 Million
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biperiden (CAS 514-65-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Biperiden (CAS 514-65-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Biperiden Hydrochloride (CAS 1235-82-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Biperiden Hydrochloride (CAS 1235-82-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025 - Product Image

Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Anticholinergic Drugs Market - Global Forecast 2026-2032 - Product Image

Anticholinergic Drugs Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Parkinson's Disease Therapeutics Market - Global Forecast 2026-2030 - Product Image

Parkinson's Disease Therapeutics Market - Global Forecast 2026-2030

  • Report
  • 183 Pages
  • Global
From

About the Biperiden Market

Biperiden is a centrally acting anticholinergic drug used to treat a variety of conditions related to the central nervous system. It is used to treat Parkinson's disease, dystonia, and drug-induced extrapyramidal reactions. It is also used to treat symptoms of Alzheimer's disease, such as memory loss, confusion, and agitation. Biperiden is also used to treat symptoms of schizophrenia, such as hallucinations, delusions, and disorganized thinking. Biperiden is available in both oral and injectable forms. It is typically taken orally in the form of tablets or capsules, and is also available as an intramuscular injection. The injectable form is used to treat severe cases of Parkinson's disease and dystonia. Biperiden is a widely used drug in the central nervous system drug market. It is used to treat a variety of conditions, and is available in both oral and injectable forms. Some companies in the Biperiden market include Pfizer, Novartis, Merck, and Sanofi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.